جست‌وجوی استاد و پژوهشگر

Beate Schwerمشاهده پروفایل

استاد

• Gene Expression
• Transcription
• RNA Processing
• +۱۲ مورد دیگر

Beate Schwer is a Professor in the Department of Microbiology and Immunology at Weill Cornell Medical College and a member of the Weill Cornell Graduate School of Medical Sciences (WCGS). Her research focuses on the molecular mechanisms of gene expression, particularly transcription and RNA processing in fission and budding yeast. She investigates the RNA Polymerase II C-terminal domain (CTD) code and its role in coordinating mRNA synthesis, termination, and phosphate homeostasis. Her research interests include: Gene Expression and Transcription Regulation RNA Polymerase II CTD Code (phosphorylation, proline isomerization) Transcriptional Interference and lncRNA Function Inositol Pyrophosphates (e.g., IP8) and Metabolite Signaling RNA 3'-Processing and Transcription Termination Chromatin Remodeling and Epigenetic Regulation Yeast Genetics and Functional Genomics The most recent 15 publications reflect a strong focus on inositol pyrophosphate metabolism, phosphate homeostasis, and the regulation of non-coding RNA-mediated gene silencing in fission yeast. Her work combines structural, biochemical, and genetic approaches to dissect how signaling metabolites interface with the transcription machinery to control gene expression. A recurring theme is the identification of suppressor mutations that rescue toxic effects of inositol pyrophosphate dysregulation, revealing novel regulatory pathways. Scientific awards and distinctions include: EMBO Fellowship (1989) New Jersey Commission on Cancer Research Award (1993) American Cancer Society Junior Faculty Research Award (1995) Fellow of the American Academy of Microbiology (2022) Dr. Schwer has been continuously funded as a Principal Investigator, including an active NIH/NIGMS grant (2023–2027) on inositol pyrophosphate dynamics in RNA 3'-processing and transcription termination. She mentors graduate students through the WCGS Molecular Biology program and leads a research program that bridges fundamental biochemistry with systems-level genetic analysis. Her lab has made seminal contributions to understanding RNA capping enzymes, splicing factors, and tRNA repair mechanisms. She has no listed formal advisees in the provided text, but her long-standing faculty role implies extensive mentorship. She is affiliated with the Microbiology and Immunology department and the Brain and Mind Research Institute.

• Plant Biology
• Molecular Biology
• Genetics
• +۳ مورد دیگر

Emily May Armstrong is a Researcher in the Department of Molecular Biosciences at the University of Glasgow. They work on plant molecular biology with a focus on circadian rhythms and RNA processing, particularly exploring temperature-responsive mechanisms in Arabidopsis. Their most recent publication (2024) in New Phytologist examines thermosensitive splicing of the REVEILLE2 gene, revealing how nocturnal temperature cues are integrated into the plant circadian clock system. This work contributes to understanding gene regulation in plant adaptability to environmental changes.

• Mitochondrial Biology
• Neuromuscular Disorders
• Electron Microscopy
• +۳ مورد دیگر

Tracey Davey is a Research Fellow at Newcastle University with an active 17-year publication record (2008-2025) in ultrastructural pathology and mitochondrial biology. Her work bridges veterinary and human medicine, focusing on neuromuscular disorders, retinal degeneration, and pancreatic pathology through advanced electron microscopy techniques. Her core research domains include: Mitochondrial dynamics in neurodegenerative and metabolic diseases Neuromuscular junction ultrastructure in equine and human disorders Retinal pigment epithelium pathology in age-related macular degeneration Quantitative electron microscopy for pancreatic stress assessment Species-specific neurotoxic mechanisms in snake venoms Analysis of her 2018-2025 publications reveals consistent methodological innovation in SBF-SEM and COX histochemistry for 3D mitochondrial mapping, with increasing focus on translational applications in mitochondrial myopathies, diabetic complications, and SARS-CoV-2 pathogenesis. Her collaborative work with Emeritus Professors Turnbull and Harris demonstrates deep integration within Newcastle's mitochondrial medicine research ecosystem. No scientific awards were documented in the source material. While student supervision details are absent, her role as consistent co-investigator on multi-author studies indicates significant mentorship contributions. No specific grant funding or laboratory leadership information was provided, though her methodological developments suggest ongoing institutional research support.

• Retinal Organoids
• Stem Cell Differentiation
• Macular Degeneration
• +۳ مورد دیگر

Dr. Valeria Chichagova is a researcher at Newcastle University , focusing on retinal organoid modeling, stem cell differentiation, and genetic mechanisms of retinal diseases. Her work spans biomedical research, ophthalmology, and regenerative medicine, with collaborations across multiple disciplines. Stargardt disease genotype-phenotype correlations IGF1/BMP4 signaling in retinal organoid differentiation Macular degeneration regeneration strategies PRPF31 gene splicing in retinitis pigmentosa Biomaterials for retinal tissue engineering Her research emphasizes the use of patient-derived models to understand disease mechanisms and develop therapeutic interventions. While no scientific awards or student mentorship details are listed in the provided data, her publications highlight expertise in stem cell biology, genetic analysis, and tissue engineering methodologies.

• Stem Cell Biology
• Ophthalmology
• Retinal Diseases
• +۳ مورد دیگر

Dr Joseph Collin is a Research Fellow at Newcastle University, Faculty of Medical Sciences, specializing in stem cell biology and ophthalmology. His work focuses on retinal disease modeling, photoreceptor regeneration, and RNA splicing mechanisms using pluripotent stem cell technologies. His primary research interests include: Stem Cell Biology: Differentiation of pluripotent stem cells into retinal lineages Ophthalmology: Modeling retinoblastoma, age-related macular degeneration, and retinitis pigmentosa Gene Editing: Zinc finger nuclease applications for photoreceptor development RNA Splicing: Investigating spliceosome defects in genetic eye disorders Single Cell Genomics: Transcriptional profiling of retinal organoids Analysis of his 15 most recent publications (2018-2024) reveals a strong trend toward single-cell resolution studies of retinal development and disease mechanisms. His work consistently leverages stem cell-derived organoids to model ocular pathologies, with significant contributions to understanding SARS-CoV-2 ocular transmission and extracellular vesicle roles in macular degeneration. Collaborations with Professor Majlinda Lako and Professor David Steel demonstrate integration within Newcastle's ophthalmology research ecosystem. Dr Collin actively participates in cellular regeneration research through Newcastle University's stem cell laboratories. His work on CRX reporter systems and photoreceptor transplantation protocols positions him at the forefront of vision restoration therapeutics, with ongoing investigations into interphotoreceptor matrix components and BMP signaling pathways in corneal differentiation.

Carina Bernardoمشاهده پروفایل

پژوهشگر

• Bladder Cancer
• Genomics
• Molecular Pathology
• +۵ مورد دیگر

Carina Bernardo is an active Associate Researcher and Urothelial Cancer Genomics Researcher at Lund University Cancer Centre (LUCC), Lund University. Her primary affiliation is with the Department of Urology (implied by email domain med.lu.se and research focus), where she serves as Principal Investigator for tumor heterogeneity projects and Assistant Supervisor for doctoral research. Her research expertise centers on bladder cancer molecular subtyping, with a fingerprint showing 100% Patient Medicine/Dentistry and 96% Bladder Cancer focus. Key areas include cancer taxonomy development (LundTax algorithm), metastasis patterns across molecular subtypes, tumor microenvironment interactions, and organoid-based drug response modeling. Recent work demonstrates limited plasticity of bladder cancer subtypes in metastatic settings and clinical utility of molecular classification for cisplatin-treated patients. Analysis of her 15 most recent publications reveals consistent focus on translational oncology, with 60% directly addressing bladder cancer molecular classification systems. Her work bridges genomics, computational biology, and clinical oncology, increasingly incorporating organoid technology and immunotherapy approaches since 2022. The 2023 Science Immunology paper on dendritic cell reprogramming (39 citations) marks expansion into tumor immunogenicity. Principal Investigator: Dissecting tumor heterogeneity with organoid models (Mrs. Berta Kamprad's Cancer Foundation, 2024-2027) Assistant Supervisor: Functional variants in breast cancer splicing (2023-present) She actively organizes LUCC symposia on advanced tumor models and imaging, with recent speaking engagements at the 2025 UroCAN Retreat and 2023 Immunology Minisymposium. Her collaborative network spans 12 international institutions focusing on bladder cancer genomics and precision oncology.

• Biomedicine and Health
• Basic Medical Sciences
• Human Genetics
• +۱۳ مورد دیگر

Petar Ozretić is an Assistant Professor and Head of the Laboratory for Hereditary Cancer at the Ruđer Bošković Institute's Division of Molecular Medicine in Zagreb, Croatia. He has established himself as a prominent researcher in molecular oncology with a focus on cancer genetics, epigenetics, and signaling pathways. His educational background includes a B.Sc. in Molecular Biology from the University of Zagreb (2005) and a Ph.D. in Biomedicine and Health from the University of Dubrovnik and Ruđer Bošković Institute (2013). Dr. Ozretić has taught numerous courses at multiple Croatian universities including the University of Zagreb, Josip Juraj Strossmayer University of Osijek, and the University of Rijeka. Dr. Ozretić's research primarily focuses on molecular mechanisms underlying cancer development, with particular emphasis on the Hedgehog-Gli signaling pathway, non-coding RNAs, and the role of various signaling molecules in tumor progression. His work spans multiple cancer types including melanoma, breast cancer, ovarian cancer, head and neck cancers, and prostate cancer. Recent publications show an increasing interest in the role of sex hormone receptors in head and neck tumors and computational studies of protein interactions. His extensive publication record demonstrates consistent research output with over 50 peer-reviewed articles, numerous book chapters, and conference proceedings. His most recent work explores the intersection of sex hormone signaling and cancer pathways, suggesting potential new therapeutic targets. FEBS bursary for attending the 34th FEBS Congress in Prague, Czech Republic FEBS bursary for attending the 35th FEBS Congress in Gothenburg, Sweden EACR Travel Fellowship FEBS Collaborative Experimental Scholarships for Central & Eastern Europe Croatian Science Foundation's Fellowship for Doctoral Students (project number 03.01/214) Dr. Ozretić has been actively involved in mentoring and teaching, having led courses on Cell Signaling Pathways, Experimental Methods in Molecular Oncology, and Molecular Diagnostics of Hereditary Tumor Diseases. He has also served as editor for multiple conference proceedings including the HDIR series (Croatian Association for Cancer Research). His laboratory focuses on hereditary cancer mechanisms, particularly investigating molecular pathways that drive tumor development and progression.

Rhiju Dasمشاهده پروفایل

استاد

• RNA Structure Prediction
• RNA Design
• Computational Biology
• +۷ مورد دیگر

Rhiju Das is a Professor of Biochemistry at Stanford University School of Medicine. He is also a member of Bio-X and the Wu Tsai Neurosciences Institute at Stanford. His research focuses on computational modeling and design of RNA molecules, with applications in biology and medicine. Dr. Das received his education from prestigious institutions: Ph.D. in Physics from Stanford University (2005) M.Res. in Biocomplexity from University College London (2000) M.Phil. in Physics (Radio Astronomy) from Cambridge University (1999) A.B. in Physics from Harvard University (1998) Dr. Das's research interests center on predicting and designing how biopolymer sequences define and regulate structure and function, with a focus on medically important RNA and RNA/protein complexes. His lab develops algorithms to predict RNA structures and energetics at high resolution, with increasing emphasis on ribosomes and viruses. They test these ideas through community-wide blind trials and by solving molecule structures using chemical mapping, NMR, crystallography, and cryo-EM data. A notable achievement includes top models in the majority of RNA-Puzzles blind structure prediction challenges. Complementing computational research, Dr. Das's lab develops biochemical methods to model unknown non-coding RNA structures, focusing on RNA structure and conformational changes in processes like splicing and mRNA transport in brain cells and viruses. They also design new RNA molecules for basic science, diagnostics, therapeutics, and vaccines through the Eterna platform, which engages citizen scientists in solving RNA design problems. Their work has produced the first algorithm for automated 3D RNA design, RNA calculators for point-of-care diagnostics, and RNA sensors for molecular computing. Dr. Das's recent publications show a strong focus on RNA structure determination using cryo-EM, RNA design through community science (Eterna), and RNA structure prediction challenges. His work spans structural biology, computational biology, and molecular engineering, with applications in virology, diagnostics, and therapeutics. Notable 2025 publications include studies of naturally ornate RNA complexes and complex water networks around RNA, while 2024 work featured RNA-Puzzles Round V, OpenASO for antisense oligonucleotide design, and Ribonanza for deep learning of RNA structure. Dr. Das has received numerous scientific awards: Gold Medal, Top US score, 2nd place worldwide, International Physics Olympiad (1995) British Marshall Scholar (1998-2000) Jane Coffin Childs Foundation Fellowship (2006-2008) Career Award at the Scientific Interface, Burroughs-Wellcome Foundation (2008-2015) Keck Medical Research Grant award (2012) OpenEye Outstanding Junior Faculty Award (2015) Discovery Innovation Award, Stanford University School of Medicine (2016) Stanford Medicine Endowed Faculty Scholar (2020-2023) Howard Hughes Medical Institute Investigator Dr. Das advises several doctoral students including Hamish Blair, Rachael Kretsch, and Georgia Tully, and serves as a co-advisor for Christian Choe. He also mentors postdoctoral scholars Alissa Hummer and Jigyasa Verma. His research is funded by multiple sources including the Howard Hughes Medical Institute, Burroughs-Wellcome Foundation, W.M. Keck Foundation, and other major grants supporting his innovative work in RNA biology and computational design. Dr. Das leads the Das Lab at Stanford, which is centered around the Eterna platform - an open science initiative that crowdsources RNA design problems to over 250,000 players of an online video game. The platform provides scoring feedback based on actual wet-lab experiments, enabling citizen scientists to contribute to RNA research. His lab also participates in major community efforts like RNA-Puzzles and CASP for RNA structure prediction assessment, and has made significant contributions to understanding RNA structure in coronaviruses, ribosomes, and other biologically important systems.

Rickard Sandbergمشاهده پروفایل

استاد

• Single-Cell Genomics
• Gene Regulation
• Computational Biology
• +۳ مورد دیگر

Rickard Sandberg is a Professor at the Department of Cell and Molecular Biology, Karolinska Institutet , and an EMBO Member (2019). He is also part of the Nobel Assembly (2019), which selects Nobel laureates in Physiology or Medicine. His research combines single-cell transcriptomics , computational biology , and robotics to decode gene regulation principles. Education : PhD in Molecular Biology (KI, 2004), Postdoc at MIT (2005-2007) Awards : Torsten Söderberg Professorship (2022), EMBO Young Investigator (2012), Anders Jahre’s Medical Prize (2014) Methods : Developed Smart-seq3xpress , NASC-seq , and Molecular Spikes for precise RNA quantification and splicing analysis. His work focuses on transcriptional bursting , splicing regulation , and RNA sequencing in clinical applications . He has published extensively in top journals like Nature , Cell , and Nature Biotechnology , often addressing cellular heterogeneity in diseases such as cancer and psychiatric disorders. Key Trends in Publications : 2024-2025 studies emphasize single-cell RNA-seq innovations , clonal mutation analysis , inflammatory gene dynamics , and splicing defects in cancer . Techniques like Smart-seq3xpress and NASC-seq dominate, with applications in neuroscience, oncology, and developmental biology. Scientific Awards : Torsten Söderberg Academy Professorship (2022) EMBO Membership (2019) Anders Jahre’s Medical Prize (2014) EMBO Young Investigator (2012) Sven and Ebba-Christina Hagbergs Prize (2012) Research Themes : Transcriptional Burst Kinetics Single-Cell Gene Expression RNA Splicing in Brain Cells Computational Tools for Transcriptomics His lab integrates dry and wet lab approaches equally, a model now standard but pioneered in 2008. Outside academia, he advocates for open scientific discourse and enjoys racket sports and cycling.

Meena Kumariمشاهده پروفایل

دانشیار

• Alcohol Use Disorder
• Cannabis Use Disorder
• Exosomes
• +۵ مورد دیگر

Meena Kumari serves as Associate Professor in the Department of Anatomy & Physiology at Kansas State University's College of Veterinary Medicine, where her research investigates molecular mechanisms underlying substance use disorders with emphasis on neurobiological pathways. Education: PhD in Andrology, University of Delhi, Delhi, India MPhil in Neuroendocrinology, University of Delhi Research Focus: Dr. Kumari's laboratory maintains two primary research trajectories: (1) Molecular analysis of alcohol-induced gene expression alterations targeting NMDA receptor regulation through RNA-protein interactions and splicing mechanisms; (2) Investigation of cannabis effects on central nervous system communication via exosomal pathways. Her methodology integrates in vivo murine models of alcohol dependence with in vitro cortical neuron systems, employing biochemical and molecular techniques to dissect neuroadaptation processes in substance use disorders. Publication Trends: Recent publications (2021-2023) demonstrate strategic expansion into exosome-mediated neurocommunication, revealing connections between extracellular vesicles and neurodegenerative processes. Earlier work (2000-2019) established foundational insights into ethanol's regulation of NMDA receptor variants through RNA-binding proteins, creating a continuum from molecular alcohol effects to contemporary cannabis-exosome investigations. Laboratory Operations: The Kumari lab maintains active research programs utilizing transgenic mouse models and primary neuronal cultures, with experimental workflows spanning molecular cloning, protein biochemistry, and cellular imaging to address neuropharmacological questions in substance use disorders.

• Virology
• Molecular Biology
• Cell Biology
• +۴ مورد دیگر

Beatriz Fontoura is a Professor in the Department of Cell Biology at the University of Texas Southwestern Medical Center, where she has been faculty since 2005 (progressing from Assistant to full Professor). Her research centers on molecular mechanisms of viral-host interactions, particularly how viruses like influenza and SARS-CoV-2 hijack host mRNA nuclear export machinery. Education: PhD in Pathology, New York University School of Medicine (1991–1996) MS in Biochemistry, Paulista School of Medicine, Brazil (1985–1988) Postdoctoral training at The Rockefeller University (1996–2001) Research Focus: Dr. Fontoura investigates nuclear pore dynamics, mRNA export pathways, and viral evasion strategies. Her work integrates structural biology, virology, and drug discovery to identify antiviral targets, including influenza NS1 and SARS-CoV-2 Orf6 proteins. Key themes include TREX-2 complex regulation, interferon signaling disruption, and phase-separated organelles. Publication Trends: Her 15 most recent articles (2016–2025) reveal a focus on viral interference with nuclear transport, structural studies of host-pathogen interfaces, and chemical inhibitors for antiviral therapy. Recurring topics include SARS-CoV-2 pathogenesis, influenza replication mechanisms, and nuclear speckle function. Leadership: She directs the Fontoura Laboratory at UT Southwestern, advancing studies in cellular virology and mRNA metabolism.

Alexander Rabchevskyمشاهده پروفایل

استاد

• Spinal Cord Injury Research
• Neuroimmunology
• Autonomic Pathophysiology
• +۳ مورد دیگر

Dr. Alexander "Sasha" Rabchevsky is a Professor of Physiology at the University of Kentucky and an inaugural member of the Spinal Cord and Brain Injury Research Center (SCoBIRC) . He combines neurophysiology with mitochondrial biology to develop innovative therapies for spinal cord injury (SCI). His research focuses on autonomic pathophysiology and bioenergetic restoration through mitoceuticals and mitochondrial transplantation. B.S. in Biology from Hampden-Sydney College (1988) Ph.D. in Neuroscience from University of Florida (1995) Postdoctoral training at INSERM U421, University of Paris XII Rabchevsky's research program investigates: Abnormal neural circuitry causing autonomic dysreflexia and muscle spasticity after SCI Mitochondrial dysfunction as a therapeutic target Mitoceutical interventions for preserving synaptic mitochondria Intraspinal mitochondria transplantation using hydrogel delivery systems His recent publications highlight mitochondrial bioenergetics and neuroimmunological interactions in SCI. Key collaborators include Dr. Stephen W. Scheff and Dr. Peter G. Sullivan. Scientific contributions include: Conquer Paralysis Awards for innovative SCI research 2018 Nature Metabolism nomenclature standard for mitochondrial transplantation He leads the Physiology Lab at SCoBIRC, conducting 24/7 telemetric cardiophysiology monitoring and Nanopore sequencing of injury-induced gene expression changes.

Thomas Okitaمشاهده پروفایل

استاد

• Plant Molecular Biology
• RNA Localization
• Starch Biosynthesis
• +۳ مورد دیگر

Thomas Okita is a Regents Professor at Washington State University (WSU), affiliated with the Department of Plant Sciences within the College of Agricultural, Human, and Natural Resource Sciences. He holds a Ph.D. in Plant Biology from the Scripps Institution of Oceanography, UC San Diego (1978). His research focuses on two primary areas: RNA localization mechanisms in plant cells and the multifunctional roles of plastidial phosphorylase in plant metabolism. In RNA localization, Okita investigates how storage protein mRNAs are targeted to specific ER subdomains in rice endosperm, identifying cis-elements and trans-factors like RNA-binding proteins (RBPs). His work employs co-immunoprecipitation, yeast 2-hybrid, and seCLIP technologies to study RBP interactomes and regulon hypotheses. In the second area, he explores the structural and functional roles of rice plastidial phosphorylase (Pho1), particularly the L80 peptide's regulatory influence on starch synthesis and photosystem I interaction. Okita's recent articles emphasize RNA-binding proteins in salt stress responses, host-pathogen interactions (e.g., Ralstonia solanacearum), and the interplay between source-sink dynamics and plant productivity. His studies bridge molecular mechanisms (e.g., transcriptome reprogramming, protein complex assembly) with applied goals like enhancing crop yields through genetic manipulation of starch metabolism. His lab, the Okita Laboratory, integrates proteomics, biochemistry, and genetic engineering to address fundamental questions in plant physiology and biotechnology. Current projects include optimizing starch synthesis pathways and dissecting the role of Pho1 in photosynthetic efficiency.

Hong Liمشاهده پروفایل

استاد

• Structural Biology
• CRISPR-Cas Systems
• Ribosome Synthesis
• +۳ مورد دیگر

Dr. Hong Li is a Professor in the Department of Structural Biology at Van Andel Institute (VAI). She leads the Hong Li Laboratory, focusing on structural mechanisms of RNA-centric processes using cryo-EM and CRISPR technologies. Her work addresses ribosome synthesis, CRISPR-Cas systems, and RNA therapeutics, with applications in cancer diagnostics and treatment. Education: B.S. in Physics (Sichuan University), Ph.D. in Biophysics (University of Rochester). Postdoctoral training at CalTech and Brookhaven National Lab. Previously held the Pfeiffer Family Endowed Professorship for Cancer Research at Florida State University, where she directed the Institute of Molecular Biophysics (2021–2024). Research Interests: Structural biology of RNA machinery, CRISPR-Cas9/CRISPR-Csm/Cmr systems, ribosome biogenesis, and translational regulation. Develops next-generation genome editing tools and nucleic acid-based diagnostics. Her lab’s cryo-EM studies reveal molecular mechanisms underlying RNA-driven processes in health and disease. Awards: AAAS Fellow, Associate Editor of The CRISPR Journal. Key achievements include structural insights into Cas9 catalytic states, ribosome pseudouridylation effects, and CRISPR-based viral detection systems. Lab Team: Includes postdoctoral fellows (Hemant Goswami, Mitchell Roth), graduate students (Renee Hoffman), and collaborators at VAI and Florida State University. Current projects target anti-cancer therapies through ribosome inhibition and epigenetic CRISPR tools. Clinical Impact: Co-developed 15 clinical trials in cancer and Parkinson’s disease through VAI partnerships. Her lab’s 2024 move to VAI leverages state-of-the-art cryo-EM facilities to advance precision medicine.

• Neuroscience
• Neurodegenerative Diseases
• Synaptic Physiology
• +۳ مورد دیگر

Murat Durakoglugil is a researcher at the University of Texas Southwestern Medical Center's School of Medicine, affiliated with the Department of Neuroscience and the Translational Neurodegeneration Research Center. His work focuses on neurodegenerative diseases, particularly Alzheimer's Disease, ApoE genetics, synaptic plasticity, and Reelin signaling mechanisms. He holds a PhD in neuroscience and conducted postdoctoral research in electrophysiology and synaptic biology. Education: PhD in Neuroscience with postdoctoral training in electrophysiology at the Neuroscience Institute, Dundee, Scotland Research Interests: His studies investigate the molecular pathways underlying neurodegeneration, including ApoE4's role in synaptic dysfunction, amyloid-β toxicity, and the neuroprotective effects of reelin. He explores therapeutic interventions targeting synaptic vesicle recycling and receptor trafficking mechanisms. Publications span over two decades, with recent emphasis on ApoE4-mediated synaptic impairments, reelin's neuroprotective role, and γ-secretase modulators for Alzheimer's biomarkers. His work integrates mouse models, in vitro electrophysiology, and translational research approaches. Labs/Teams: Active in the Translational Neurodegeneration Research Center, collaborating on projects involving ApoE receptor biology and synaptic dysfunction in neurodegenerative diseases.